{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:07:37Z","timestamp":1789171657830,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-08310-8","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:06:20Z","timestamp":1781874380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and risk factors of bipolar disorder in central nervous system autoimmune demyelinating diseases"],"prefix":"10.1186","volume":"26","author":[{"given":"Omid","family":"Mirmosayyeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepehr","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Vaheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fateme","family":"Mohammadifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Sharbafchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Shaygannejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"3","key":"8310_CR1","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1212\/CON.0000000000000732","volume":"25","author":"WO Tobin","year":"2019","unstructured":"Tobin WO. Management of Multiple Sclerosis Symptoms and Comorbidities. Continuum (Minneap Minn). 2019;25(3):753\u201372.","journal-title":"Continuum (Minneap Minn)"},{"issue":"2","key":"8310_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/ebmental-2020-300207","volume":"24","author":"B Joseph","year":"2021","unstructured":"Joseph B, et al. Prevalence of bipolar disorder in multiple sclerosis: a systematic review and meta-analysis. Evid Based Ment Health. 2021;24(2):88\u201394.","journal-title":"Evid Based Ment Health"},{"issue":"3","key":"8310_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1352458514564487","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler. 2015;21(3):305\u201317.","journal-title":"Mult Scler"},{"issue":"22","key":"8310_CR4","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1212\/WNL.0000000000002174","volume":"85","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, et al. Differences in the burden of psychiatric comorbidity in MS vs the general population. Neurology. 2015;85(22):1972\u20139.","journal-title":"Neurology"},{"issue":"12","key":"8310_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.30773\/pi.2019.0106","volume":"16","author":"C Silveira","year":"2019","unstructured":"Silveira C, et al. Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art. Psychiatry Investig. 2019;16(12):877\u201388.","journal-title":"Psychiatry Investig"},{"issue":"12","key":"8310_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s11910-016-0706-x","volume":"16","author":"AP Turner","year":"2016","unstructured":"Turner AP, et al. Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder. Curr Neurol Neurosci Rep. 2016;16(12):106.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"4","key":"8310_CR7","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/mp.2017.73","volume":"23","author":"DP Hibar","year":"2018","unstructured":"Hibar DP, et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Mol Psychiatry. 2018;23(4):932\u201342.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"8310_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1176\/appi.neuropsych.15120403","volume":"29","author":"AH Jun-O\u2019Connell","year":"2017","unstructured":"Jun-O\u2019Connell AH, et al. The Prevalence of Bipolar Disorders and Association With Quality of Life in a Cohort of Patients With Multiple Sclerosis. J Neuropsychiatry Clin Neurosci. 2017;29(1):45\u201351.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"14","key":"8310_CR9","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1177\/1352458514540970","volume":"20","author":"V Johansson","year":"2014","unstructured":"Johansson V, et al. Multiple sclerosis and psychiatric disorders: comorbidity and sibling risk in a nationwide Swedish cohort. Mult Scler. 2014;20(14):1881\u201391.","journal-title":"Mult Scler"},{"issue":"1","key":"8310_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nbd.2011.01.025","volume":"45","author":"C Konradi","year":"2012","unstructured":"Konradi C, Daws SE, Clay HB. Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dis. 2012;45(1):37\u201347.","journal-title":"Neurobiol Dis"},{"key":"8310_CR11","doi-asserted-by":"publisher","first-page":"102564","DOI":"10.1016\/j.msard.2020.102564","volume":"46","author":"L Lorefice","year":"2020","unstructured":"Lorefice L, et al. Bipolar disorders and deep grey matter in multiple sclerosis: A preliminary quantitative MRI study. Mult Scler Relat Disord. 2020;46:102564.","journal-title":"Mult Scler Relat Disord"},{"key":"8310_CR12","doi-asserted-by":"publisher","first-page":"102128","DOI":"10.1016\/j.msard.2020.102128","volume":"42","author":"Z Ebadi","year":"2020","unstructured":"Ebadi Z, et al. Evaluation of types of psychological disorders in patients with neuromyelitis optica spectrum disorder (NMOSD). Mult Scler Relat Disord. 2020;42:102128.","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"8310_CR13","doi-asserted-by":"publisher","first-page":"e0300777","DOI":"10.1371\/journal.pone.0300777","volume":"19","author":"DC Esiason","year":"2024","unstructured":"Esiason DC, et al. The psychological burden of NMOSD \u2013 a mixed method study of patients and caregivers. PLoS ONE. 2024;19(3):e0300777.","journal-title":"PLoS ONE"},{"key":"8310_CR14","doi-asserted-by":"crossref","unstructured":"Liu J, et al. The prevalence of depression, anxiety, and sleep disturbances in patients with neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis. Mult Scler Relat Disord. 2023:79.","DOI":"10.1016\/j.msard.2023.105007"},{"issue":"2","key":"8310_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162\u201373.","journal-title":"Lancet Neurol"},{"issue":"2","key":"8310_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177\u201389.","journal-title":"Neurology"},{"key":"8310_CR17","unstructured":"Mitra Hakim S, et al. Structured Clinical Interview for DSM-IV (SCID): Persian translation and cultural adaptation. Iran J Psychiatry. 1970;2(1)."},{"key":"8310_CR18","doi-asserted-by":"crossref","unstructured":"Mirmosayyeb O, et al. Bipolar disorder in people with multiple sclerosis: an updated systematic review and meta-analysis. BMC Psychiatry. 2026.","DOI":"10.1186\/s12888-026-07839-y"},{"key":"8310_CR19","doi-asserted-by":"publisher","first-page":"105023","DOI":"10.1016\/j.actpsy.2025.105023","volume":"256","author":"S Amiri","year":"2025","unstructured":"Amiri S, Moayed MS, Satkin M. Age-and sex-specific analysis of the impact of bipolar disorder in Iran and its provinces: Prevalence, incidence, and disability-adjusted life years: Global burden of disease 2021. Acta Psychol. 2025;256:105023.","journal-title":"Acta Psychol"},{"issue":"1","key":"8310_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/1352458515579439","volume":"22","author":"M Deppe","year":"2016","unstructured":"Deppe M, et al. Evidence for early, non-lesional cerebellar damage in patients with multiple sclerosis: DTI measures correlate with disability, atrophy, and disease duration. Mult Scler. 2016;22(1):73\u201384.","journal-title":"Mult Scler"},{"issue":"3","key":"8310_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/hbm.20077","volume":"24","author":"A Jansen","year":"2005","unstructured":"Jansen A, et al. Crossed cerebro\u2013cerebellar language dominance. Hum Brain Mapp. 2005;24(3):165\u201372.","journal-title":"Hum Brain Mapp"},{"issue":"12","key":"8310_CR22","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1093\/brain\/awr266","volume":"134","author":"AM Tedesco","year":"2011","unstructured":"Tedesco AM, et al. The cerebellar cognitive profile. Brain. 2011;134(12):3672\u201386.","journal-title":"Brain"},{"issue":"2","key":"8310_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/biomedicines11020309","volume":"11","author":"G Olivito","year":"2023","unstructured":"Olivito G, et al. The cerebellum gets social: evidence from an exploratory study of cerebellar, neurodevelopmental, and psychiatric disorders. Biomedicines. 2023;11(2):309.","journal-title":"Biomedicines"},{"key":"8310_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neulet.2018.07.005","volume":"688","author":"JD Schmahmann","year":"2019","unstructured":"Schmahmann JD. The cerebellum and cognition. Neurosci Lett. 2019;688:62\u201375.","journal-title":"Neurosci Lett"},{"key":"8310_CR25","doi-asserted-by":"publisher","first-page":"105775","DOI":"10.1016\/j.msard.2024.105775","volume":"89","author":"YY Tan","year":"2024","unstructured":"Tan YY, et al. The burden of psychiatric morbidity in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD before and after neurological diagnosis. Multiple Scler Relat Disorders. 2024;89:105775.","journal-title":"Multiple Scler Relat Disorders"},{"key":"8310_CR26","doi-asserted-by":"crossref","unstructured":"Correa-D\u00edaz EP et al. Neuropsychiatric disorders among Ecuadorian patients with multiple sclerosis and neuromyelitis optica spectrum disorder. Front Neurol. 2025;16.","DOI":"10.3389\/fneur.2025.1587804"},{"issue":"5","key":"8310_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/archneur.1997.00550170015009","volume":"54","author":"DC Mohr","year":"1997","unstructured":"Mohr DC, et al. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol. 1997;54(5):531\u20133.","journal-title":"Arch Neurol"},{"issue":"1","key":"8310_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41380-021-01091-4","volume":"27","author":"P Magioncalda","year":"2022","unstructured":"Magioncalda P, Martino M. A unified model of the pathophysiology of bipolar disorder. Mol Psychiatry. 2022;27(1):202\u201311.","journal-title":"Mol Psychiatry"},{"key":"8310_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.pscychresns.2018.09.005","volume":"281","author":"N Piaggio","year":"2018","unstructured":"Piaggio N, et al. Exploring mania-associated white matter injury by comparison with multiple sclerosis: a diffusion tensor imaging study. Psychiatry Res Neuroimaging. 2018;281:78\u201384.","journal-title":"Psychiatry Res Neuroimaging"},{"issue":"2","key":"8310_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/mp.2013.195","volume":"20","author":"OA Andreassen","year":"2015","unstructured":"Andreassen OA, et al. Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci. Mol Psychiatry. 2015;20(2):207\u201314.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"8310_CR31","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S0278-5846(03)00116-7","volume":"27","author":"VP Bozikas","year":"2003","unstructured":"Bozikas VP, et al. Familial bipolar disorder and multiple sclerosis: a three-generation HLA family study. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(5):835\u20139.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8310_CR32","doi-asserted-by":"publisher","first-page":"p101177","DOI":"10.1016\/j.bbih.2026.101177","volume":"52","author":"Q Xu","year":"2026","unstructured":"Xu Q, et al. AQP4-IgG and mood disorders: Case series of neuromyelitis optica spectrum disorder. Brain Behav Immun - Health. 2026;52:p101177.","journal-title":"Brain Behav Immun - Health"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08310-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08310-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08310-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:02:35Z","timestamp":1788436955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08310-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8310"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08310-8","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"15 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study and its procedures were performed in accordance with the Declaration of Helsinki and its amendments and was approved by the Ethics Committee of Isfahan University of Medical Sciences (IR.ARI.MUI.REC.1401.061). All included patients provided written informed consent after a full explanation of study protocol.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"693"}}